{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:23Z","timestamp":1791287003475,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>\n                    A high homocysteine (Hcy) level is a risk factor for schizophrenia, depression, and bipolar disorder. However, the role of hyperhomocysteinemia as either an independent factor or an auxiliary contributor to specific psychiatric symptoms or disorders remains unclear. This study aimed to examine Hcy levels in first-episode inpatients with psychotic symptoms and various psychiatric diseases to elucidate the association between Hcy levels and psychiatric disorders. This study enrolled 191 patients (aged 18\u201340 years) with psychiatric disorders. Seventy-five patients were diagnosed with schizophrenia, 48 with acute and transient psychotic disorders, 36 with manic episodes with psychosis, 32 with major depressive episodes with psychosis, and 56 healthy controls. Serum Hcy levels were measured using the enzyme cycle method. A Hcy concentration level of &amp;gt; 15 \u03bcmol\/L was defined as hyperhomocysteinemia. Hcy levels were significantly higher in first-episode patients with psychiatric disorders compared to healthy controls (5.99 \u00b1 3.60 vs. 19.78 \u00b1 16.61 vs. 15.50 \u00b1 9.08 vs. 20.00 \u00b1 11.33 vs. 16.22 \u00b1 12.06,\n                    <jats:italic>F<\/jats:italic>\n                    = 12.778,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001). Hcy levels were significantly higher in males with schizophrenia, acute and transient psychotic disorder, and major depressive disorder but not in mania [schizophrenia, (\n                    <jats:italic>t<\/jats:italic>\n                    = -4.727,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001); acute and transient psychotic disorders, (\n                    <jats:italic>t<\/jats:italic>\n                    = -3.389,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.001); major depressive episode with psychosis, (\n                    <jats:italic>t<\/jats:italic>\n                    = -3.796,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001); manic episodes with psychosis, (\n                    <jats:italic>t<\/jats:italic>\n                    = -1.684,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.101)]. However, serum Hcy levels were not significantly different among the psychiatric disorder groups (\n                    <jats:italic>F<\/jats:italic>\n                    = 0.139,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.968). Multivariate linear regression showed that males had an increased risk for homocysteinemia. (95% CI = 8.192\u201315.370,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001). These results suggest that first-episode patients with psychiatric disorders have higher Hcy levels than in the general population, and men are at greater risk for psychiatric disorders. In conclusion, elevated Hcy levels may contribute to the pathogenesis of first-episode patients with psychotic symptoms.\n                  <\/jats:p>","DOI":"10.3389\/fpsyt.2024.1380900","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:14:13Z","timestamp":1716426853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Homocysteine levels in first-episode patients with psychiatric disorders"],"prefix":"10.3389","volume":"15","author":[{"given":"Ning","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050737","article-title":"Homocysteine: biochemistry, molecular biology and role in disease","volume":"11","author":"Hermann","year":"2021","journal-title":"Biomolecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/00365513.2023.2167232","article-title":"Association of methylene tetrahydrofolate reductase (Mthfr) gene polymorphisms with serum folate, cobalanin and homocysteine concentrations in greek adults","volume":"83","author":"Mazokopakis","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2147\/ndt.s399378","article-title":"Vitamin B12, folate, homocysteine, inflammatory mediators (Interleukin-6, tumor necrosis factor-\u03b1 and C-reactive protein) levels in adolescents with anxiety or depressive symptoms","volume":"19","author":"Tan","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.08.032","article-title":"Association between high bmi and high homocysteine levels in chinese patients with bipolar disorder","volume":"295","author":"Mu","year":"2021","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.25440","article-title":"Homocysteine and small vessel stroke: A mendelian randomization analysis","volume":"85","author":"Larsson","year":"2019","journal-title":"Ann Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2018.10.010","article-title":"Homocysteine and age-associated disorders","volume":"49","author":"Ostrakhovitch","year":"2019","journal-title":"Ageing Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7394699","article-title":"Serum levels of hcy, mif, and hs-crp correlate with glycolipid metabolism in adults with never-medicated first-episode schizophrenia","volume":"2021","author":"Zhong","year":"2021","journal-title":"Evidence-Based Complementary Altern Med: eCAM"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18502\/ijps.v15i4.4292","article-title":"Relationship between serum homocysteine and metabolic syndrome among patients with schizophrenia and bipolar disorder: A cross sectional study","volume":"15","author":"Fe'li","year":"2020","journal-title":"Iran J Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.08.022","article-title":"Interactive effects of elevated homocysteine and late-life depression on cognitive impairment","volume":"277","author":"Zhou","year":"2020","journal-title":"J Affect Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.931560","article-title":"Elevated homocysteine levels, white matter abnormalities and cognitive impairment in patients with late-life depression","volume":"14","author":"Zhou","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.08.063","article-title":"Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a han chinese population","volume":"259","author":"Zhou","year":"2018","journal-title":"Psychiatry Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2019.1710250","article-title":"Homocysteine, chronotype and clinical course in bipolar disorder patients","volume":"74","author":"Ozdogan","year":"2020","journal-title":"Nord J Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e13486","DOI":"10.1111\/eci.13486","article-title":"The association between serum homocysteine and depression: A systematic review and meta-analysis of observational studies","volume":"51","author":"Moradi","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.976428","article-title":"Association between variants of mthfr genes and psychiatric disorders: A meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eurpsy.2017.02.482","article-title":"Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis","volume":"43","author":"Salagre","year":"2017","journal-title":"Eur Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01150-x","article-title":"Prevalence and clinical demography of hyperhomocysteinemia in han chinese patients with schizophrenia","volume":"271","author":"Yang","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.04.025","article-title":"Effect of risperidone on serum homocysteine levels in first-episode, drug-na\u00efve patients with schizophrenia","volume":"650","author":"Fan","year":"2017","journal-title":"Neurosci Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e45734","DOI":"10.7759\/cureus.45734","article-title":"Bibliometric analysis of the 100 most-cited articles on periodontics in the arab world","volume":"15","author":"Aljabbary","year":"2023","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19716","DOI":"10.1038\/s41598\u2013021-99239\u20133","article-title":"Association between plasma homocysteine levels and cognitive deficits in han chinese patients with schizophrenia across age groups","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112890","article-title":"DNA methylation and schizophrenia: current literature and future perspective","volume":"10","author":"Magwai","year":"2021","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12275\u2013022-1451\u20132","article-title":"Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine","volume":"60","author":"Tian","year":"2021","journal-title":"J Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2021\u20130164","article-title":"Gut dysbiosis and homocysteine: A couple for boosting neurotoxicity in huntington disease","volume":"33","author":"Mart\u00ednez-Lazcano","year":"2022","journal-title":"Rev Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41398\u2013018-0276\u20136","article-title":"Methylenetetrahydrofolate reductase and psychiatric diseases","volume":"8","author":"Wan","year":"2018","journal-title":"Trans Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00925-x","article-title":"Diet and depression: exploring the biological mechanisms of action","volume":"26","author":"Marx","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12011\u2013017-1214\u20139","article-title":"Improved sp1 and betaine homocysteine-S-methyltransferase expression and homocysteine clearance are involved in the effects of zinc on oxidative stress in high-fat-diet-pretreated mice","volume":"184","author":"Wu","year":"2018","journal-title":"Biol Trace Element Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2021.126814","article-title":"Higher serum homocysteine and lower thyroid hormone levels in pregnant women are associated with neural tube defects","volume":"68","author":"Gu","year":"2021","journal-title":"J Trace Elem Med Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2019.17.2.318","article-title":"Alexithymia, suicide ideation and homocysteine levels in drug na\u00efve patients with major depression: A study in the real world clinical practice","volume":"17","author":"Berardis","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1152\/physrev.00003.2018","article-title":"Homocysteine modification in protein structure\/function and human disease","volume":"99","author":"Jakubowski","year":"2019","journal-title":"Physiol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2021.2016954","article-title":"Predictive value of oxidative stress biomarkers in drug-free patients with bipolar disorder","volume":"76","author":"Guidara","year":"2022","journal-title":"Nord J Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071386","article-title":"Oxidative stress and psychiatric disorders: evidence from the bidirectional mendelian randomization study","volume":"11","author":"Lu","year":"2022","journal-title":"Antioxidants"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2022.11.009","article-title":"Betaine supplementation improves positive symptoms in schizophrenia","volume":"250","author":"Kirihara","year":"2022","journal-title":"Schizophr Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x20666220201084536","article-title":"DNA methylation in depression and depressive-like phenotype: biomarker or target of pharmacological intervention","volume":"20","author":"Musazzi","year":"2022","journal-title":"Curr Neuropharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1380900\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:14:16Z","timestamp":1716426856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1380900\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":32,"alternative-id":["10.3389\/fpsyt.2024.1380900"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1380900","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"article-number":"1380900"}}